In addition, the observed stroke risk reduction for ILR screening versus usual care in the participant group with NT-proBNP >15 pmol/L seems to be attributable mainly to OAC initiation upon AF detection rather than risk factor management, as no significant difference in SBP reduction during follow-up was found across the randomization groups among these participants. The gene discussed is NPPB; the disease is atrial fibrillation.